Literature DB >> 27867621

Von Willebrand factor, paravalvular leak, and a new vista for TAVR.

Neal S Kleiman1, Michael J Reardon1.   

Abstract

Entities:  

Year:  2016        PMID： 27867621      PMCID： PMC5107522          DOI： 10.21037/jtd.2016.10.61

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

Authors:  Svenja Lippok; Matthias Radtke; Tobias Obser; Lars Kleemeier; Reinhard Schneppenheim; Ulrich Budde; Roland R Netz; Joachim O Rädler
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

2.  Two-year outcomes after transcatheter or surgical aortic-valve replacement.

Authors:  Susheel K Kodali; Mathew R Williams; Craig R Smith; Lars G Svensson; John G Webb; Raj R Makkar; Gregory P Fontana; Todd M Dewey; Vinod H Thourani; Augusto D Pichard; Michael Fischbein; Wilson Y Szeto; Scott Lim; Kevin L Greason; Paul S Teirstein; S Chris Malaisrie; Pamela S Douglas; Rebecca T Hahn; Brian Whisenant; Alan Zajarias; Duolao Wang; Jodi J Akin; William N Anderson; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

3.  Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials.

Authors:  Neal S Kleiman; Brijeshwar J Maini; Michael J Reardon; John Conte; Stanley Katz; Vivek Rajagopal; James Kauten; Alan Hartman; Raymond McKay; Robert Hagberg; Jian Huang; Jeffrey Popma
Journal:  Circ Cardiovasc Interv       Date:  2016-09       Impact factor: 6.546

4.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Authors:  A Pieter Kappetein; Stuart J Head; Philippe Généreux; Nicolo Piazza; Nicolas M van Mieghem; Eugene H Blackstone; Thomas G Brott; David J Cohen; Donald E Cutlip; Gerrit-Anne van Es; Rebecca T Hahn; Ajay J Kirtane; Mitchell W Krucoff; Susheel Kodali; Michael J Mack; Roxana Mehran; Josep Rodés-Cabau; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys; Martin B Leon
Journal:  Eur Heart J       Date:  2012-10       Impact factor: 29.983

5.  1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

Authors:  Ian T Meredith; Darren L Walters; Nicolas Dumonteil; Stephen G Worthley; Didier Tchétché; Ganesh Manoharan; Daniel J Blackman; Gilles Rioufol; David Hildick-Smith; Robert J Whitbourn; Thierry Lefèvre; Rüdiger Lange; Ralf Müller; Simon Redwood; Ted E Feldman; Dominic J Allocco; Keith D Dawkins
Journal:  JACC Cardiovasc Interv       Date:  2016-02-22       Impact factor: 11.195

6.  Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.

Authors:  E Fressinaud; A Veyradier; M Sigaud; C Boyer-Neumann; C Le Boterff; D Meyer
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

7.  Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

Authors:  Jeffrey J Popma; David H Adams; Michael J Reardon; Steven J Yakubov; Neal S Kleiman; David Heimansohn; James Hermiller; G Chad Hughes; J Kevin Harrison; Joseph Coselli; Jose Diez; Ali Kafi; Theodore Schreiber; Thomas G Gleason; John Conte; Maurice Buchbinder; G Michael Deeb; Blasé Carabello; Patrick W Serruys; Sharla Chenoweth; Jae K Oh
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

8.  Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.

Authors:  Eric Van Belle; Antoine Rauch; Flavien Vincent; Emmanuel Robin; Marion Kibler; Julien Labreuche; Emmanuelle Jeanpierre; Marie Levade; Christopher Hurt; Natacha Rousse; Jean-Baptiste Dally; Nicolas Debry; Jean Dallongeville; Andre Vincentelli; Cedric Delhaye; Jean-Luc Auffray; Francis Juthier; Guillaume Schurtz; Gilles Lemesle; Thibault Caspar; Olivier Morel; Nicolas Dumonteil; Alain Duhamel; Camille Paris; Annabelle Dupont-Prado; Paulette Legendre; Frederic Mouquet; Berenice Marchant; Sylvie Hermoire; Delphine Corseaux; Karim Moussa; Aurelie Manchuelle; Jean-Jacques Bauchart; Valentin Loobuyck; Claudine Caron; Christophe Zawadzki; Fabrice Leroy; Jean-Christophe Bodart; Bart Staels; Jenny Goudemand; Peter J Lenting; Sophie Susen
Journal:  N Engl J Med       Date:  2016-07-28       Impact factor: 91.245

9.  Acquired von Willebrand syndrome in aortic stenosis.

Authors:  André Vincentelli; Sophie Susen; Thierry Le Tourneau; Isabelle Six; Olivier Fabre; Francis Juthier; Anne Bauters; Christophe Decoene; Jenny Goudemand; Alain Prat; Brigitte Jude
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

10.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L Nolasco; J D Hellums
Journal:  Blood       Date:  1988-05       Impact factor: 22.113
View more
  1 in total

1.  Pathologic Shear and Elongation Rates Do Not Cause Cleavage of Von Willebrand Factor by ADAMTS13 in a Purified System.

Authors:  Maria Bortot; Alireza Sharifi; Katrina Ashworth; Faye Walker; Allaura Cox; Katherine Ruegg; Nathan Clendenen; Keith B Neeves; David Bark; Jorge Di Paola
Journal:  Cell Mol Bioeng       Date:  2020-07-17       Impact factor: 2.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.